Drugs for COVID-19: An Update

被引：21

作者：

Ceramella, Jessica ^{[1
]}

Iacopetta, Domenico ^{[1
]}

Sinicropi, Maria Stefania ^{[1
]}

Andreu, Inmaculada ^{[2
,3
]}

Mariconda, Annaluisa ^{[4
]}

Saturnino, Carmela ^{[4
]}

Giuzio, Federica ^{[4
]}

Longo, Pasquale ^{[5
]}

Aquaro, Stefano ^{[1
]}

Catalano, Alessia ^{[6
]}

机构：

[1] Univ Calabria, Dept Pharm Hlth & Nutr Sci, I-87036 Arcavacata Di Rende, Italy

[2] Univ Politecn Valencia, Dept Quim, Camino Vera s-n, Valencia 46022, Spain

[3] Hosp Univ & Politecn La Fe, Un Mixta Invest UPV IIS La Fe, Ave Fernando Abril Martorell 106, Valencia 46026, Spain

[4] Univ Basilicata, Dept Sci, I-85100 Potenza, Italy

[5] Univ Salerno, Dept Chem & Biol, Via Giovanni Paolo II,132, I-84084 Fisciano, Italy

[6] Univ Bari Aldo Moro, Dept Pharm Drug Sci, I-70126 Bari, Italy

来源：

MOLECULES | 2022年 / 27卷 / 23期

关键词：

antibiotics; anticoagulants; antivirals; COVID-19; interleukin inhibitors; JAKs inhibitors; immunomodulators; NSAIDs; SARS-CoV-2; HYDROXYCHLOROQUINE;

D O I：

10.3390/molecules27238562

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19.

引用

页数：17

共 98 条

[1] Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection [J].